Brief: Dr Reddy's Says FDA Issued Form 483 With 4 Observations After Inspection Of Hyderabad Formulations Facility
14/08/2026 19:04
BRIEF-Dr Reddy's Says FDA Issued Form 483 With 4 Observations After Inspection Of Hyderabad Formulations Facility Aug 14 (Reuters) - Dr Reddy's Laboratories Ltd REDY.NS:
USFDA COMPLETES GMP INSPECTION AT FTO-3 FACILITY IN HYDERABAD AUG 6-14, 2026
ISSUED FORM 483 WITH FOUR OBSERVATIONS AFTER USFDA INSPECTION
Source text: ID:nBSE3FCHjz
Further company coverage: REDY.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr. Reddy's Laboratories
See all newsDr Reddy's rolls out new generic Ozempic brands to ease Obeda supply hit
Dr Reddy's beats quarterly profit estimate on India market lift (updated)
India's Dr Reddy's beats quarterly profit estimate
Brief: Dr. Reddy's Q2 Consol Net PAT 9.25 Billion Rupees
Dr Reddy's rolls out new generic Ozempic brands amid Obeda supply disruption